The U.S. Food and Drug Administration has approved the use of the CSL Limited’s 2009 H1N1 influenza vaccine to include children ages 6 months and older. This vaccine was previously approved only for use in adults, ages 18 years and older.
“Because children are among those most vulnerable to the 2009 H1N1 virus, having a broader range of children’s vaccines available is an important step in responding to the H1N1 outbreak,” said Margaret A. Hamburg, M.D., commissioner of food and drugs.
The vaccines will be available in single-dose, preservative-free, pre-filled syringes and in multi-dose vials that contain thimerosal, a mercury derivative, as a preservative.'
Read more...
Margaret Hamburg is a member of the Council on Foreign Relations, A Director of Vaccine Equipment supplier Henry Schein, Professor at Rockefeller University and trustee of the Rockefeller Foundation.
See here...
No comments:
Post a Comment
Thanks for your comment it is much appreciated.